Academic Company Events NI Developer Zone Support Solutions Products & Services Contact NI MyNI

Document Type: Instrumentation Newsletter
NI Supported: Yes
Publish Date: Aug 7, 2008


Feedback


Yes No

Related Links - Developer Zone

Related Links - Products and Services

Advanced Cancer Research with PXI and LabVIEW

2 ratings | 5.00 out of 5
Print

THE CHALLENGE

Developing a medical instrument for earlier cancer detection that does not require the patient to experience severe stress.

THE SOLUTION

Using the NI LabVIEW graphical programming environment and the PXI platform to develop the world’s fastest optical coherence tomography (OCT) medical imaging acquisition system.

We chose the NI platform because of its synchronization capabilities, small size,and modularity to enable high-channel-count acquisitions.

OCT is a noninvasive, nonradiation imaging technique used for tissue visualization. Images captured using OCT are higher in resolution than images captured using techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET). Recently, as a method to help detect cancer sooner and ultimately enhance the quality of life for patients, our research groups at Kitasato University in Japan developed the fastest OCT imaging system in the world.

Using the National Instruments PXI platform and other innovative technologies, we developed a data acquisition system that breaks a broadband light source into 256 separate frequency bands. All emitted frequencies are simultaneously acquired on 256 synchronized channels at 60 MS/s using NI PXI-5105 digitizers. We then analyze the acquired data and recreate the OCT image using LabVIEW.

With the NI platform, we built the world’s fastest OCT system, a huge advancement toward our goal of detecting cancer cells sooner.

Dr. K. Ohbayashi Kitasato

University, Japan

Watch a video on building high-channel-count digitizer systems.

This article first appeared in the Q3 2008 issue of Instrumentation Newsletter. 

2 ratings | 5.00 out of 5
Print

Reader Comments | Submit a comment »

 

Legal
This material is protected under the copyright laws of the U.S. and other countries and any uses not in conformity with the copyright laws are prohibited, including but not limited to reproduction, DOWNLOADING, duplication, adaptation and transmission or broadcast by any media, devices or processes.